The benefits of a public pharmacist service in chronic hepatitis C treatment: The real-life results of sofosbuvir-based therapy

Gomes, Lenyta Oliveira; Teixeira, Marina Rodrigues; Rosa, Júnior André da; Foppa, Aline Aparecida; Rover, Marina Raijche Mattozo; Farías, Mareni Rocha

doi:10.1016/j.sapharm.2019.02.008

Cited by 4 publications

(4 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…SVR rates reached 93.9% and were in accordance with data from clinical trials and real-world studies, [18][19][20][21][22][23][24] including Brazilian studies. 20,21,25 All of the schemes used showed a high percentage of cures, higher than those obtained with the previous treatments, in a shorter time frame, in addition to a lower incidence of adverse effects compared with other studies. 23,[26][27][28][29] We did not perform the incremental cost-effectiveness analysis because each therapeutic scheme was selected according to the hepatitis C virus genotype and clinical criteria of the patient.…”

Section: Clinical Outcomesmentioning

confidence: 70%

Cost and Effectiveness of the Treatment of Chronic Hepatitis C in Brazil: Real-World Data

Schwambach¹,

Farías

Neto

et al. 2020

Value in Health Regional Issues

Self Cite

View full text Add to dashboard Cite

Section: Clinical Outcomesmentioning

confidence: 70%

Cost and Effectiveness of the Treatment of Chronic Hepatitis C in Brazil: Real-World Data

Schwambach¹,

Farías

Neto

et al. 2020

Value in Health Regional Issues

Self Cite

View full text Add to dashboard Cite

“…An indication of this difficulty is the low number of studies. Only ten studies on medication therapy management (Andrade et al, 2009;Garabeli et al, 2016;Gomes et al, 2020;Melo, Castro, 2017;Mendonça et al, 2016;Obreli-Neto et al, 2011a, 2011bSantos Júnior et al, 2020;Scarabelin et al, 2019) included in this review were related to service implementation. Other publications refer to services offered for scientific purposes, including pilot studies developed during the research period only and not as continued services offered by a community pharmacy.…”

Section: Discussionmentioning

confidence: 99%

Mapping community pharmacy services in Brazil: a scoping review

Garabeli

Benetoli

Halila

et al. 2022

Braz. J. Pharm. Sci.

View full text Add to dashboard Cite

The delivery of clinical pharmacy services has been growing in Brazilian community pharmacies, and it is necessary to have a comprehensive understanding of the topic. This scoping review aimed to provide an overview of Brazilian studies about clinical pharmacy services in community pharmacies. Original research articles, with no restriction of time, study design, or patient's health condition, were included. Searches were conducted in PubMed, Scopus, Web of Science, Scielo, and Lilacs. Two reviewers conducted the screening, full-text reading, and data extraction independently. ROB and ROBINS-I were used for the assessment of quality. Charts and tables were built to summarise the data. Seventy-two articles were included. A diversity of study designs, number of participants, terms used, and outcomes was found. São Paulo and Sergipe States had the highest number of studies (n=10). Pharmacists' interventions were not fully reported in 65% of studies, and most studies presented an unclear risk of bias. Studies were very diverse, impairing the comparisons between the results and hindering their reproducibility. This review suggests using guidelines and checklists for better structuration of pharmacists' interventions as well as reporting results and measuring fidelity in future research.

show abstract

“…De igual forma, podría aplicarse en otras enfermedades de transmisión sexual y enfermedades crónicas de alto costo. caso de terapias con ribavirina o interferón] y función renal) (8,19,22,30,35,36,42,47 mejorar la aceptabilidad y favorecer las actitudes positivas entre el personal de la farmacia para impulsar estos servicios (9,12). Adicionalmente, es necesario el establecimiento de relaciones públicas y estrategias de mercadeo para aumentar la visibilidad del farmacéutico comunitario (farmacias y droguerías) en este rol ampliado de atención al paciente y determinar un modelo para obtener el reembolso por su actividad y por los servicios ofrecidos en el punto de atención (9).…”

Section: Discussionunclassified

“…Mediante este proceso, las empresas aseguradoras determinan si el tratamiento es médicamente necesario y adecuado según el diagnóstico y condición del paciente (6). Los farmacéuticos han trabajado en la coordinación de dicho proceso, en la adquisición, dispensación de medicamentos (2,6,22,23,(25)(26)(27)36), optimización de la terapia y control del gasto (Figura 4) (44).…”

Section: Gestión Administrativaunclassified

Rol del farmacéutico en la atención integral de pacientes con hepatitis C: revisión sistemática

Morales

Salazar-Ospina

Amariles

et al. 2020

Rev Colomb Gastroenterol

View full text Add to dashboard Cite

Objetivo: Identificar y caracterizar las acciones/intervenciones realizadas desde los servicios farmacéuticos en el abordaje de pacientes con Hepatitis C y proponer una vía clínica para la gestión de la enfermedad que incluya la participación del farmacéutico. Método: Revisión sistemática en PubMed y EMBASE empleando los términos "Hepatitis C", "Pharmaceutical Services", "Community Pharmacy Services", y "Pharmacies"; artículos publicados hasta el 31 de marzo de 2019, cuyo tema central fueran las actividades realizadas por los servicios farmacéuticos en la atención a pacientes con Hepatitis C. Se recopiló información sobre: actividad realizada, responsable, si la intervención era individual o colectiva y el entorno de aplicación. Las actividades se agruparon en: promoción y prevención, gestión administrativa, atención farmacéutica, investigación y otros servicios de apoyo. De acuerdo a esto, se propuso una vía clínica para el manejo de la Hepatitis C con participación del farmacéutico. Resultados: se incluyeron 60 artículos, principalmente de estudios descriptivos. La mayoria de las publicaciones reportaron intervenciones realizadas en Estados Unidos y España. Se identificó la participación del personal farmacéutico en cada una de las etapas del proceso de atención, incluyendo: provisión de servicios de reducción del daño, tamizaje del Virus de la Hepatitis C, vinculación de los pacientes al tratamiento, prescripción de medicamentos y órdenes de laboratorio. Conclusiones: Se identifican y caracterizan las acciones/intervenciones realizadas desde el servicio farmacéutico para el manejo de la Hepatitis C y se propone una vía clínica en la que se integran los servicios profesionales farmacéuticos a las demás actividades de la atención del paciente.

show abstract

The benefits of a public pharmacist service in chronic hepatitis C treatment: The real-life results of sofosbuvir-based therapy

Cited by 4 publications

References 16 publications

Cost and Effectiveness of the Treatment of Chronic Hepatitis C in Brazil: Real-World Data

Cost and Effectiveness of the Treatment of Chronic Hepatitis C in Brazil: Real-World Data

Mapping community pharmacy services in Brazil: a scoping review

Rol del farmacéutico en la atención integral de pacientes con hepatitis C: revisión sistemática

Contact Info

Product

Resources

About